Article
Genomic epidemiology of Colombian resistant Candida auris isolates.
Antimicrobial agents and chemotherapy - 5 Nov 2025
Alvarado Casas Maira Lyseth, Triana Díaz Jeisson Alejandro, Montilla-Escudero Efrain, Prada Cardozo Diego Andrés, Escandón Hernández Patricia
Abstract excerpt
Since 2016, Candida auris has been subject to mandatory reporting in Colombia due to its critical public health implications. In this context, a genomic characterization of clinical C. auris isolates collected between 2018 and 2024 through national surveillance led by the Instituto Nacional de Salud (INS) was conducted. Twenty-seven isolates from hospitalized patients across 14 departments were analyzed using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
